05:29 PM EDT, 10/20/2025 (MT Newswires) -- Lexeo Therapeutics ( LXEO ) said late Monday it had closed its previously announced public offering and concurrent private placement, raising approximately $153.8 million in gross proceeds, including the full exercise of underwriters' option to purchase additional shares.

In the public offering, Lexeo issued 17.97 million shares of common stock at $8.00 per share, generating approximately $143.8 million in gross proceed, the company said.

Concurrently, Lexeo raised about $10 million through a private placement of pre-funded warrants for 1.25 million shares to Balyasny Asset Management, it added.

Lexeo Therapeutics ( LXEO ) were up 3% on Monday after hours trading.